353 related articles for article (PubMed ID: 29809001)
1. Self-Assembly of Extracellular Vesicle-like Metal-Organic Framework Nanoparticles for Protection and Intracellular Delivery of Biofunctional Proteins.
Cheng G; Li W; Ha L; Han X; Hao S; Wan Y; Wang Z; Dong F; Zou X; Mao Y; Zheng SY
J Am Chem Soc; 2018 Jun; 140(23):7282-7291. PubMed ID: 29809001
[TBL] [Abstract][Full Text] [Related]
2. Evaluating UiO-66 Metal-Organic Framework Nanoparticles as Acid-Sensitive Carriers for Pulmonary Drug Delivery Applications.
Jarai BM; Stillman Z; Attia L; Decker GE; Bloch ED; Fromen CA
ACS Appl Mater Interfaces; 2020 Sep; 12(35):38989-39004. PubMed ID: 32805901
[TBL] [Abstract][Full Text] [Related]
3. MOF-derived novel porous Fe
Xiang Z; Qi Y; Lu Y; Hu Z; Wang X; Jia W; Hu J; Ji J; Lu W
J Mater Chem B; 2020 Sep; 8(37):8671-8683. PubMed ID: 32856668
[TBL] [Abstract][Full Text] [Related]
4. Stimuli-responsive multifunctional metal-organic framework nanoparticles for enhanced chemo-photothermal therapy.
Feng J; Xu Z; Dong P; Yu W; Liu F; Jiang Q; Wang F; Liu X
J Mater Chem B; 2019 Feb; 7(6):994-1004. PubMed ID: 32255104
[TBL] [Abstract][Full Text] [Related]
5. Magnetically Driven Nanotransporter-Assisted Intracellular Delivery and Autonomous Release of Proteins.
Cheng G; Han X; Zheng SY
ACS Appl Mater Interfaces; 2020 Sep; 12(37):41096-41104. PubMed ID: 32811148
[TBL] [Abstract][Full Text] [Related]
6. One-Pot Preparation of Peptide-Doped Metal-Amino Acid Framework for General Encapsulation and Targeted Delivery.
Mugaka BP; Zhang S; Li RQ; Ma Y; Wang B; Hong J; Hu YH; Ding Y; Xia XH
ACS Appl Mater Interfaces; 2021 Mar; 13(9):11195-11204. PubMed ID: 33645961
[TBL] [Abstract][Full Text] [Related]
7. Core-Shell Nanosystems for Self-Activated Drug-Gene Combinations against Triple-Negative Breast Cancer.
Liu P; Liu X; Cheng Y; Zhong S; Shi X; Wang S; Liu M; Ding J; Zhou W
ACS Appl Mater Interfaces; 2020 Dec; 12(48):53654-53664. PubMed ID: 33205940
[TBL] [Abstract][Full Text] [Related]
8. A tumor-cell biomimetic nanoplatform embedding biological enzymes for enhanced metabolic therapy.
Ji P; Wang TY; Luo GF; Chen WH; Zhang XZ
Chem Commun (Camb); 2021 Sep; 57(74):9398-9401. PubMed ID: 34528964
[TBL] [Abstract][Full Text] [Related]
9. A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy.
Xie W; Zhang Y; Xu Q; Zhong G; Lin J; He H; Du Q; Tan H; Chen M; Wu Z; Deng Y; Han Z; Lu J; Ye J; Zou F; Zhuo Y; Zhong W
Int J Nanomedicine; 2024; 19():3957-3972. PubMed ID: 38711614
[TBL] [Abstract][Full Text] [Related]
10. Hierarchical Self-assembly of Discrete Metal-Organic Cages into Supramolecular Nanoparticles for Intracellular Protein Delivery.
Liu J; Luo T; Xue Y; Mao L; Stang PJ; Wang M
Angew Chem Int Ed Engl; 2021 Mar; 60(10):5429-5435. PubMed ID: 33247547
[TBL] [Abstract][Full Text] [Related]
11. Photo-triggered release of 5-fluorouracil from a MOF drug delivery vehicle.
Roth Stefaniak K; Epley CC; Novak JJ; McAndrew ML; Cornell HD; Zhu J; McDaniel DK; Davis JL; Allen IC; Morris AJ; Grove TZ
Chem Commun (Camb); 2018 Jul; 54(55):7617-7620. PubMed ID: 29926872
[TBL] [Abstract][Full Text] [Related]
12. Dual Roles of Metal-Organic Frameworks as Nanocarriers for miRNA Delivery and Adjuvants for Chemodynamic Therapy.
Zhao H; Li T; Yao C; Gu Z; Liu C; Li J; Yang D
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6034-6042. PubMed ID: 33499584
[TBL] [Abstract][Full Text] [Related]
13. ZnO nanocrystals shuttled by extracellular vesicles as effective Trojan nano-horses against cancer cells.
Dumontel B; Susa F; Limongi T; Canta M; Racca L; Chiodoni A; Garino N; Chiabotto G; Centomo ML; Pignochino Y; Cauda V
Nanomedicine (Lond); 2019 Nov; 14(21):2815-2833. PubMed ID: 31747855
[No Abstract] [Full Text] [Related]
14. Glutathione-responsive nanoscale MOFs for effective intracellular delivery of the anticancer drug 6-mercaptopurine.
Gong M; Yang J; Li Y; Gu J
Chem Commun (Camb); 2020 Jun; 56(47):6448-6451. PubMed ID: 32393947
[TBL] [Abstract][Full Text] [Related]
15. Biomimetic nanocarrier for direct cytosolic drug delivery.
Zhang Z; Cao W; Jin H; Lovell JF; Yang M; Ding L; Chen J; Corbin I; Luo Q; Zheng G
Angew Chem Int Ed Engl; 2009; 48(48):9171-5. PubMed ID: 19876988
[No Abstract] [Full Text] [Related]
16. Efficient enzyme-activated therapy based on the different locations of protein and prodrug in nanoMOFs.
Wang F; Yang J; Li Y; Zhuang Q; Gu J
J Mater Chem B; 2020 Jul; 8(28):6139-6147. PubMed ID: 32568339
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte Membrane Cloaked Metal-Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy.
Zhang L; Wang Z; Zhang Y; Cao F; Dong K; Ren J; Qu X
ACS Nano; 2018 Oct; 12(10):10201-10211. PubMed ID: 30265804
[TBL] [Abstract][Full Text] [Related]
18. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
19. A biomimetic MOF nanoreactor enables synergistic suppression of intracellular defense systems for augmented tumor ablation.
Gao P; Shi M; Wei R; Pan W; Liu X; Li N; Tang B
Chem Commun (Camb); 2020 Jan; 56(6):924-927. PubMed ID: 31850458
[TBL] [Abstract][Full Text] [Related]
20. Metal Organic Framework (MOF) Particles as Potential Bacteria-Mimicking Delivery Systems for Infectious Diseases: Characterization and Cellular Internalization in Alveolar Macrophages.
Guo A; Durymanov M; Permyakova A; Sene S; Serre C; Reineke J
Pharm Res; 2019 Feb; 36(4):53. PubMed ID: 30790066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
